Učitavanje...
FGFR-gerichtete Therapie von Kopf-Hals-Karzinomen
BACKGROUND: Genomic aberrations (mutations, gene fusions, amplifications) and dysregulation of the fibroblast growth factor (FGF) receptor (FGFR) signaling pathway are frequently found in squamous cell carcinomas of the head and neck (HNSCCs). Targeted therapy with tyrosine kinase inhibitors (TKIs)...
Spremljeno u:
| Izdano u: | HNO |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Medizin
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7902560/ https://ncbi.nlm.nih.gov/pubmed/32519203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00106-020-00893-2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|